| Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results from a large … DYC Heng, W Xie, MM Regan, MA Warren, AR Golshayan, C Sahi, ... Journal of clinical oncology 27 (34), 5794-5799, 2009 | 1462 | 2009 |
| Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... Journal of the National cancer Institute 103 (22), 1656-1664, 2011 | 1401 | 2011 |
| Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk HK Meier-Ewert, PM Ridker, N Rifai, MM Regan, NJ Price, DF Dinges, ... Journal of the American College of Cardiology 43 (4), 678-683, 2004 | 1059 | 2004 |
| Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma DF McDermott, MM Regan, JI Clark, LE Flaherty, GR Weiss, TF Logan, ... Journal of clinical oncology 23 (1), 133-141, 2004 | 885 | 2004 |
| Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial V Galimberti, BF Cole, S Zurrida, G Viale, A Luini, P Veronesi, P Baratella, ... The lancet oncology 14 (4), 297-305, 2013 | 879 | 2013 |
| Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ... Cell 138 (2), 245-256, 2009 | 853 | 2009 |
| The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer MM Pomerantz, N Ahmadiyeh, LI Jia, P Herman, MP Verzi, ... Nature genetics 41 (8), 882-884, 2009 | 672 | 2009 |
| Adjuvant exemestane with ovarian suppression in premenopausal breast cancer O Pagani, MM Regan, BA Walley, GF Fleming, M Colleoni, I Láng, ... New England Journal of Medicine 371 (2), 107-118, 2014 | 643 | 2014 |
| Adjuvant ovarian suppression in premenopausal breast cancer PA Francis, MM Regan, GF Fleming, I Láng, E Ciruelos, M Bellet, ... New England Journal of Medicine 372 (5), 436-446, 2015 | 585 | 2015 |
| External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study DYC Heng, W Xie, MM Regan, LC Harshman, GA Bjarnason, ... The lancet oncology 14 (2), 141-148, 2013 | 563 | 2013 |
| De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 G Curigliano, HJ Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, ... Annals of Oncology 28 (8), 1700-1712, 2017 | 560 | 2017 |
| Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer M Atkins, M Regan, D McDermott, J Mier, E Stanbridge, A Youmans, ... Clinical cancer research 11 (10), 3714-3721, 2005 | 499 | 2005 |
| Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy … G Viale, MM Regan, E Maiorano, MG Mastropasqua, P Dell'Orto, ... Journal of Clinical Oncology 25 (25), 3846-3852, 2007 | 437 | 2007 |
| Association of cystic fibrosis with abnormalities in fatty acid metabolism SD Freedman, PG Blanco, MM Zaman, JC Shea, M Ollero, IK Hopper, ... New England Journal of Medicine 350 (6), 560-569, 2004 | 383 | 2004 |
| Melatonin treatment for age-related insomnia IV Zhdanova, RJ Wurtman, MM Regan, JA Taylor, JP Shi, OU Leclair The Journal of Clinical Endocrinology & Metabolism 86 (10), 4727-4730, 2001 | 366 | 2001 |
| Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical … MM Regan, P Neven, A Giobbie-Hurder, A Goldhirsch, B Ejlertsen, ... The lancet oncology 12 (12), 1101-1108, 2011 | 360 | 2011 |
| 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC N Ahmadiyeh, MM Pomerantz, C Grisanzio, P Herman, L Jia, V Almendro, ... Proceedings of the National academy of sciences 107 (21), 9742-9746, 2010 | 348 | 2010 |
| Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International … G Viale, A Giobbie-Hurder, MM Regan, AS Coates, MG Mastropasqua, ... Journal of clinical oncology 26 (34), 5569, 2008 | 338 | 2008 |
| CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial MM Regan, B Leyland-Jones, M Bouzyk, O Pagani, W Tang, R Kammler, ... Journal of the National Cancer Institute 104 (6), 441-451, 2012 | 323 | 2012 |
| Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer G Viale, the International Breast Cancer Study Group, MM Regan, ... JNCI: Journal of the National Cancer Institute 100 (3), 207-212, 2008 | 274 | 2008 |
